The present invention is directed to a stent comprising (a) a balloon expandable coronary stent; and (b) paclitaxel, in an amount that when tested in a chick chorioallantoic membrane assay is anti-angiogenic. ...http://www.google.fr/patents/US7820193?utm_source=gb-gplus-shareBrevet US7820193 - Anti-angiogenic compositions and methods of use
